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ABSTRACT In previous studies, we identified a locus
for schizophrenia on 6q23.3 and proposed the Abelson
helper integration site 1 (AHI1) as the candidate gene.
AHI1 is expressed in the brain and plays a key role in
neurodevelopment, is involved in Joubert syndrome,
and has been recently associated with autism. The
neurodevelopmental role of AHI1 fits with etiological
hypotheses of schizophrenia. To definitively confirm
our hypothesis, we searched for associations using a
dense map of the region. Our strongest findings lay
within the AHI1 gene: single-nucleotide polymorphisms
rs11154801 and rs7759971 showed significant associa-
tions (P6.23E-06; P0.84E-06) and haplotypes gave P
values in the 10E-8 to 10E-10 range. The second
highest significant region maps close to AHI1 and
includes the intergenic region between BC040979 and
PDE7B (rs2038549 at P9.70E-06 and rs1475069 at
P6.97E-06), and PDE7B and MAP7. Using a sample of
Palestinian Arab families to confirm these findings, we
found isolated signals. While these results did not
retain their significance after correction for multiple
testing, the joint analysis across the 2 samples supports
the role of AHI1, despite the presence of heterogeneity.
Given the hypothesis of positive selection of schizo-
phrenia genes, we resequenced a 11 kb region within
AHI1 in ethnically defined populations and found evi-
dence for a selective sweep. Network analysis indicates
2 haplotype clades, with schizophrenia-susceptibility
haplotypes clustering within the major clade. In conclu-
sion, our data support the role of AHI1 as a suscepti-
bility gene for schizophrenia and confirm it has been
subjected to positive selection, also shedding light on
new possible candidate genes, MAP7 and PDE7B.—
Torri, F., Akelai, A., Lupoli, S., Sironi, M., Amann-
Zalcenstein, D., Fumagalli, M., Dal Fiume, C., Ben-
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Schizophrenia is a severe psychiatric disorder that
has an important genetic component with heritability
estimates around 80% (1) but no clearly defined
mode of inheritance (2). Genetic epidemiological stud-
ies support a complex, “multifactorial,” mode of trans-
mission (3).
Family, twin, and adoption studies initially demon-
strated the importance of this genetic component (4).
Linkage studies subsequently implicated several chro-
mosomal regions, but these were not fully replicated
across different studies. Nevertheless, a certain cover-
gence of positive linkage findings in specific chromo-
somal regions has emerged in different meta-analyses
(5–7) and reviews (8–10): the most promising putative
susceptibility genes are dysbindin (DNTB1), neuregulin
1 (NRG1), d-amino acid oxidase (DAO), d-amino acid
oxidase activator (DAOA; formerly known as G72),
regulator of G-protein signaling 4 (RGS4), catechol-O-
methyltransferase (COMT), and disrupted in schizo-
phrenia 1 (DISC1).
To date, 10 genome-wide association studies of
schizophrenia have been published (11–20): while evi-
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dence has accumulated for several possible risk genes
for schizophrenia (including some findings replicated
across different large samples), specific susceptibility
variants have yet to be discovered. The nature and
degree of interactions and the specific risk conferred by
each gene also remain to be characterized. Four recent
genome wide copy number variants (CNVs) studies for
the contribution of large (100 kb) CNVs suggest that
also rare (inherited or de novo) and highly penetrant
structural variants may also be relevant to schizophre-
nia (16, 21–24), in particular CNVs that disrupt genes
involved in brain development. However, the definitive
contribution of common and rare CNVs to schizophre-
nia has not been clarified.
Intriguingly, several of the genes pinpointed by these
studies are involved in brain development, in line with
the neurodevelopmental model that has been a domi-
nant explanatory theory for schizophrenia for more
than 2 decades (25, 26).
The long arm of chromosome 6 stands among the
most replicated and confirmed linkage findings (7,
27–35), with the 6q15–23.2 locus suggested as a strong
schizophrenia candidate region (7). The same region
seems also to be involved in bipolar disorder (7,
36–38). In a previous genome-wide linkage analysis, we
first reported strong evidence for a positive finding on
chromosome 6q23.3 (39) and then (40) further refined
the confidence linkage interval from 126.0 to 146.0 Mb,
with the peak at 136.3 Mb. This region was then
analyzed using 180 single-nucleotide polymorphisms
(SNPs) within and flanking 20 putative candidate genes
expressed in brain and potentially relevant for the
pathophysiology of schizophrenia (41). The 7 signifi-
cantly overtransmitted alleles were then replicated by
an independent Icelandic case control study (42). Our
data led to the identification of a 500-kb genomic
region significantly associated with schizophrenia even
after correction for multiple testing.
This region harbors the Abelson helper integration
site 1 gene (AHI1) and BC040979 (previously known as
C6orf217), an adjacent primate-specific gene currently
identified as hypothalamic mRNA. The upstream re-
gion may contain regulatory elements for AHI1 and
also for the distally located PDE7B gene. AHI1 is
expressed in brain (43), and its role in neurodevelop-
ment is suggested by its involvement not only in schizo-
phrenia but also in Joubert syndrome (gene mutation;
ref. 44) and autism (association study, 45). Interest-
ingly, these 2 diseases often share behavioral traits (46).
Schizophrenia and autism, both psychoses, are now
independent diseases in the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV; ref.
47), but intriguingly the term “autism” was first used by
Bleuler (48) to describe some of the schizophrenic
features.
Our main aim was to unequivocally confirm AHI1 as
a susceptibility gene for schizophrenia by performing a
dense and fine linkage disequilibrium (LD) mapping
involving 2019 SNPs in the same Arab-Israeli sample
that allowed the initial identification of the region. We
also fine-genotyped a different sample of Arab families
(129 nuclear families) with 1375 SNPs in the same
9-Mb interval. Our second goal was to confirm
whether AHI1 has been subjected to natural selection
in humans given the previously reported evidence that
a portion of genes putatively related to schizophrenia
(49) may be fast evolving and the recent suggestion of
AHI1 as a target of positive selection (50, 51).
MATERIALS AND METHODS
Family samples and diagnostic methods
We studied 2 different samples of Arab origin, the TKT and
BT samples (39–41). The index family-based association
sample for this study (TKT) was slightly enlarged from
previous work (41) and consisted of 58 nuclear families of
Arab-Israeli origin including a total of 198 individuals, 99 of
which are affected (89 probands and 10 parents; Table 1). We
did not have the DNA of 16 individuals. The sample is drawn
from an ethnically homogenous population that originated
30 generations ago with a limited number of founders and
that shows a high birth rate, an unusually high level of
consanguinity, and a low rate of intermarriage with other
population groups in Israel (52, 53). Thirty-six are trio
families (affected proband with both parents), while 22 have
multiple affected offspring (11 with 2, 6 with 3, 2 with 4, and
3 with 5–7). To establish psychiatric diagnosis, TKT subjects
were interviewed with the Schedule for Affective Disorders
and Schizophrenia–Lifetime Version (SADS-L; ref. 54) and
were questioned about psychiatric symptoms in the family
according to the Family History Research Diagnostic Criteria
(FH-RDC; ref. 55). Medical records of hospitalizations and
clinic care were obtained for affected individuals. The com-
pleted SADS-L interview form, FH-RDC information, and
medical records were reviewed by 2 experienced members of
the research team and, in cases where consensus was not
achieved, by the principal investigator (B.L.). Lifetime diag-
noses were established according to the Research Diagnostic
Criteria (RDC; ref. 54) and the DSM-IV (47) using a best
estimate consensus procedure (56). All diagnostic evaluations
were completed without knowledge of the genotyping data. A
broad diagnostic category was employed, and this encom-
passed 79 subjects with schizophrenia, 17 with schizoaffective
disorder, and 3 with unspecified functional psychosis (RDC;
ref. 54).
The BT sample is also of Arab origin but is outbred and was
recruited from different geographical regions of Israel and
the Palestinian Authority. The sample consisted of 129 nu-
clear families with a total of 421 individuals, 165 of whom are
affected (165 probands, no affected parents). The sample is
made up of 105 trio families and 24 families with multiple
affected offspring (18 with 2, 2 with 3, 2 with 4, and 2 with 5).
For the BT sample, the affected individuals were diagnosed
with schizophrenia according to DSM-IV (47) on the basis of
interview with the Structured Clinical Interview for DSM-IV
Axis I Disorders (SCID; ref. 57). All BT subject were diag-
nosed with schizophrenia. We evaluated the reliability of
diagnoses across the 2 samples by independent assessment, as
TABLE 1. Description of the BT and TKT samples and the
number of SNPs genotyped across the 2 datasets
Sample
Nuclear
families (n) Probands (n)
Genotyped
SNPs (n)
TKT 58 89 2019
BT 129 165 1375
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detailed in Amann-Zalcenstein et al. (41; also see Supplemen-
tal Material).
The project was approved by the Hadassah–Hebrew Uni-
versity Medical Centre Helsinki Committee (Internal Review
Board), and informed consent for inclusion in this study was
given by all the subjects.
Genotyping
Genomic DNA was extracted using standard methods. Geno-
typing was performed at the University of Milan, using 2
complementary DNA microarray approaches (58, 59). For the
TKT sample, we performed a whole-genome scan with the
humancnv370 chip (Illumina, San Diego, CA, USA) assaying
370,404 SNPs, among which 1183 mapped within the 131.32–
140.24 linkage region in 6q23–24 reported by Amann-Zalcen-
stein et al. (41). We increased the map density in this region
with 836 additional SNPs using a custom SNP array, the
Golden Gate Genotyping Assay (Illumina). In total, we geno-
typed 2019 SNPs within the identified linkage region
(131.32–140.24 Mb). To select the SNPs to be genotyped with
the custom array, we identified the best tagging SNPs within
the 131.32–140.24 region in 6q23–24, in addition to those
present on humancnv370 array.
Among all SNPs, 88 had been genotyped in the previously
reported study of Amann-Zalcenstein et al. (41; for the
complete list see Supplemental Table S2). The average inter-
marker distance is 4.9 kb, with the smallest and the largest
gaps being 14 and 43.2 kb, respectively. In this way, we
reached a 3.5-fold greater coverage than the previously per-
formed studies in the 1-Mb area around the linkage peak that
in Amann-Zalcenstein et al. (41) showed the highest SNP
density and a 13.6-fold greater coverage for the remaining
region.
We also genotyped the BT sample with 1375 SNPs, selected
as the most informative from the panel of 2019 markers of the
TKT sample and mapping in the same linkage interval
(131.32–140.24 Mb) using again a Golden Gate Genotyping
Assay. In both the TKT and BT samples, the AHI1 gene was
densely covered (by 27 and 22 informative SNPs, respec-
tively).
Normalized bead intensity data obtained for each sample
were analyzed with the Illumina Genome Studio v1.0.2 soft-
ware, which generated SNP genotypes from fluorescent in-
tensities using the manufacturer’s default cluster settings.
Quality controls included evaluation of call rate; check of
SNPs with 1) no calls, 2) with a minor allele frequency
(MAF)  0.05, and 3) with a genotyping rate 0.9. SNPs that
did not match these criteria were removed from further
analyses. Also, individuals with missing genotyping 10%
were not included in the analyses. An additional quality
control step was performed to exclude individuals and/or
markers based on Mendelian error rate (PLINK 1.04; ref, 60;
http://pngu.mgh.harvard.edu/purcell/plink/). SNPs with
10% and families with 5% Mendelian errors were dis-
carded. In addition, SNPs that showed a significant deviation
from Hardy-Weinberg Equilibrium (HWE; P0.00001) were
flagged for evaluation before excluding them from further
analyses. In particular, we specifically checked whether SNPs
mapping to the AHI1 locus significantly deviated from HWE
equilibrium (P0.00001) in parents or in affected offspring,
given the different meaning of deviation from HWE in
“normal” compared with “affected” subjects (61–63).
We used Haploview 4.00 (ref. 64; http://www.broad.mit.
edu/mpg/haploview/) to calculate intermarker LD between
all SNP pairs within a 1-Mb interval and to generate a
graphical view of the LD pattern across the entire genomic
region. Haplotype blocks were defined using the 4-gamete
rule algorithm (65).
Genetic power calculation were performed with the Ge-
netic Power Calculator tool (ref. 66; http://pngu.mgh.harvard.
edu/purcell/gpc/).
Association analyses
We used PBAT 3.6 (refs. 67, 68; http://www.biostat.harvard.
edu/), which incorporates an extended and improved trans-
mission disequilibrium test (TDT; ref. 69), to perform asso-
ciation analyses under the null hypothesis of “previous link-
age and no association” with the sandwich option (sw) for
robust estimation of the variance, conditioning on traits and
parental genotypes. Following the same strategy as Amann-
Zalcenstein et al. (41), we also performed a 3-SNP “sliding-
window” haplotype analysis as implemented in PBAT. Haplo-
type analysis was restricted to adjacent SNPs and was
performed using the additive model, given that schizophrenia
follows a complex mode of inheritance. The minimal number
of informative families was set to 10, and the minimal
haplotype cutoff frequency was set to 0.05. Correction for
multiple testing was performed using the qFDR value, which is
an extension of the false discovery rate (FDR) method (70).
The q values were calculated with the QVALUE R package
using the smoother method (71).
The Search Tool for the Retrieval of Interacting Genes/
Proteins (STRING; ref. 72) was used to find protein interac-
tion information. SNP annotation was based on the most
recent version of both GenomeBuild (Build36.3) and dbSNP
(release 129). The networks shown were generated through
the use of the Ingenuity Pathways Analysis classification
system (Ingenuity Systems, Redwood City, CA, USA; http://
www.ingenuity.com).
Joint-analyses of BT and TKT association results
We performed a joint analysis between TKT and BT sample
association results for the SNPs (Table 2) and the haplotype
windows mapping in and/or near AHI1 showing the best
association P values in the TKT sample. An overall odds ratio
(OR) and 95% confidence interval was estimated under the
Mantel-Haenszel’s fixed effects model (73) using a METAN
routine implemented in STATA. The number of each transmit-
ted allele from heterozygous parents to affected offspring was
treated as the number of occurrences of that “risk” or “norisk”
allele in cases. The controls were assumed from a very large
population with equal numbers of each allele (to reflect
TABLE 2. Original and surrogate alleles tested for association in TKT and BT populations
Sample
Marker
rs7759971-C rs11554801-C rs1475069-A rs2038549-G
TKT rs7759971-C rs11554801-C rs1475069-A rs2038549-G
BT rs7759971-C rs9647365-A rs1475069-A rs2038549-G
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the expected 50:50 transmission ratio from parents to
offspring (74).
Evolutionary analysis of AHI1
DNA samples and sequencing
Human genomic DNA was obtained from the Coriell Institute
for Medical Research (Camden, NJ, USA). All analyzed
regions were PCR amplified and directly sequenced (primer
sequences are available on request). PCR products were
treated with ExoSAP-IT (USB Corporation, Cleveland, OH,
USA), directly sequenced on both strands with a Big Dye
Terminator Sequencing Kit (v3.1 Applied Biosystems, Foster
City, CA, USA) and run on an Applied Biosystems ABI 3130
XL Genetic Analyzer. Sequences were assembled using Au-
toAssembler version 1.4.0 (Applied Biosystems) and in-
spected manually by 2 distinct operators. Genomic coordi-
nates [National Center for Biotechnology Information
(NCBI) Build 36.1] for the resequenced region are chr6:
135713023-135724493.
Data retrieval and haplotype construction
Genotype data for 238 resequenced human genes were
derived from the National Institute of Environmental Health
Sciences (NIEHS) SNP program web site (http://egp.gs.
washington.edu/). Haplotypes were inferred using PHASE
2.1 (75, 76), a program for reconstructing haplotypes from
unrelated genotype data through a Bayesian statistical
method.
Statistical analysis
Tajima’s D (77), Fu and Li’s D* and F* (78) statistics, as well
as diversity parameters W (79) and  (80) and Fay and Wu’s
H (81) were calculated using libsequence (82). Calibrated
coalescent simulations were performed using the “cosi” pack-
age (83) and its best-fit parameters for YRI and EA with
10,000 iterations. The Ewens-Watterson homozygosity test
(79) was performed using Arlequin (84). The maximum-
likelihood-ratio HKA test was performed using the maximum-
likelihood-ratio HKA (MLHKA) software (85) using multilo-
cus data from 16 NIEHS genes, as described previously (86).
Median-joining networks to infer haplotype genealogy were
constructed using Network 4.5 (87).
RESULTS
Summary statistics
We genotyped a 9-Mb linkage interval on chromo-
some 6q, starting at 131.32 Mb and ending at 140.24
Mb (genome Build36.3), using 2019 SNPs in the TKT
sample and 1375 in the BT sample. This region harbors
58 known genes (including 1 known miRNA, hsa-mir-
548a-2), 43 of which are mapped by 1 of the geno-
typed SNPs. Of these 2019 SNPs, 88 were included in
our previous study (41; for a complete list see Supple-
mental Table S2). Four of those 88 common SNPs had
inconsistent genotypes with our previous report (41)
and were thus removed (see Supplemental Table S3).
We verified that the positions of the 88 genotyped
SNPs did not vary between the build (Build 36.3) used
for the SNP annotation with that used by Amann-
Zalcenstein et al. (41). In the current dbSNP129 re-
lease, 8 of the 2019 SNPs are not present, but none of
them maps in the AHI1 region of interest (see Supple-
mental Table S1). Quality control procedures and
results are summarized in Supplemental Table S4. Our
sample is powered enough to detect a significant asso-
ciation with a TDT design (66).
LD structure and single-SNP association analysis
Within the genotyped9-Mb interval, we identified in the
TKT sample a region (135.6–136.9 Mb) showing a highly
conserved LD structure as also present in reference Hap-
Map populations (Fig. 1). This region includes the AHI1,
PDE7B, and MAP7 genes, each covered by well-defined
LD blocks (Fig. 1 and Supplemental Material). Our best
association findings fall exactly within this region (Fig. 2,
red arrow).
Table 3 and Fig. 2 show the results of the best single
SNP association analysis (see Supplemental Table S6
for the complete list of all the P and qFDR values for all
SNPs in the entire region).
Among the 68 SNPs genotyped in this area, 53 show a
nominal significant P value, and 33 are still significant
after FDR correction (Table 3). The strongest associated
SNPs are the same as those previously reported by Amann-
Zalcenstein et al. (41), namely rs11154801 (P6.23E-06;
qFDR1.09E-04) and rs7759971 (P1.84E-06; qFDR 8.61E-
05). They are included in a region of 500 kb (135.6–
136.1 Mb) encompassing the AHI1 and BC040979
genes, as indicated by a red arrow in Fig. 2. These 2
genes map very close to each other, within a 61-bp
interval, and lie in a very high LD region that extends
downstream the 5 of AHI1 (here downstream means
at the 3 of AHI1, so toward the telomere) distally.
Here we found 2 additional significant SNPs, rs2038549
(P9.70E-06; qFDR2.77E-003) and rs1475069 (P6.97E-
06; qFDR2.39E-03). This region may contain sequences
possibly having a regulatory role for both AHI1 and
PDE7B given that the 2 genes are transcribed in opposite
direction. Across the entire 9-Mb genotyped region, no
other SNP shows association with a P value 10E-5, but
there are several SNPs with P values ranging from 10E-3 to
10E-4 (Supplemental Table S6).
For the BT population, only 3 SNPs reach P values of
10E-04, none of which survives FDR correction (rs6929048:
P7.59E-04, qFDR0.370174; rs1414980: P8.03E-04,
qFDR0.370174 in EYA4 gene; rs6570251: P 8.22E-04,
qFDR0.370174; see Supplemental Table S7 and Sup-
plemental Fig. S1). Single SNP association results for
the AHI1-BC040979-PDE7B-MAP7 locus in BT sample
are summarized in Supplemental Table S8.
A joint analysis for our most significantly associated
SNPs (rs7759971 and rs11154801 within AHI1 and
intergenic SNPs rs2038549 and rs1475069) in the TKT
and BT samples shows significant heterogeneity across
the 2 samples (MH-het P values from 0.002 to 0.035;
Table 4). The ORs for associations have values ranging
from 1.2 to 1.88 similar to other SNPs found associated
to schizophrenia in other published papers [see for
example Allen et al. (10) and other studies in the
Introduction].
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The second most significant genic region in TKT
sample includes the PDE7B and MAP7 genes. Of 106
SNPs, 22 yielded values of P 0.05, the most significant
being rs2142921 (P2.20E-03; qFDR9.46E-02) and
rs9376173 (P6.41E-03; qFDR9.96E-01), but none of
these survived FDR correction (see Supplemental Table
S5). Figure 3 summarizes these results, also showing the
transcription polarity of the genes.
Across AHI1, BC040979, PDE7B, and MAP7 genes, we
observed deviation from HWE for 15 SNPs in affected
individuals only. Three of these SNPs map in the AHI1
gene (rs2614276, rs11154801, and rs12206850) and 4
in BC040979 (rs10484771, rs4896156, rs2143681, and
rs3734213). In both cases, these SNPs are also signifi-
cantly associated to schizophrenia. For the remaining 9
SNPs, 8 map in the intergenic region between
BC040979 and PDE7B.
Haplotype association analyses
To improve the informativeness of single SNP associa-
tion analysis, we performed a 3-SNP sliding-window
haplotype analysis. In the TKT sample, we detected a
total of 6137 individual haplotypes (Supplemental Ta-
ble S11), and we corrected with the FDR procedure
(70). In the AHI1-PDE7B-MAP7 region (Fig. 4A), we
detected a total of 576 individual haplotypes (Supple-
Figure 1. Genomic region on chromosome 6q23 for fine mapping of a schizophrenia susceptibility locus in an Arab-Israeli
sample. A) Distribution of known genes spanning a 9-Mb genomic region underneath a previously shown linkage peak for
schizophrenia in the same Arab-Israeli sample. B) General overview of the haplotype blocks detected with Haploview software.
Black rectangle contains the haplotype blocks mapping in the region encompassing the AHI1, BC040979, PDE7B, and MAP7
genes. C, D) Zoomed views of boxed area in B for TKT sample (C) and HapMap subjects (D).
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mental Table S9). We found an outstanding haplotype
association signal with P  10E-10 within AHI1 with
haplotype windows encompassing SNPs in very high LD
with rs1154801, the top associated SNP, and with
rs9321501, which was contained in the most signifi-
cantly associated haplotype windows in the previous
Amann-Zalcenstein et al. (41) work (Fig. 4B and Table
4). These haplotype windows did not display any signif-
icant association to schizophrenia in the BT sample
(Supplemental Table S10 and full results in Supple-
mental Table S12). The joint analysis with BT haplo-
type association analyses for these TKT best 2 windows
displayed combined ORs of 1.3, again strengthening
the significance of this association signal given also the
extremely higher weight of BT sample on the analysis.
Evolutionary analysis of AHI1
Previous analyses of human/primate divergence indi-
cated that the 5 region of the human AHI1 has
undergone directional selection (43). Also, a genome-
wide search (50) for genes subjected to recent positive
selection based on extreme FST values indicated both
AHI1 and PDE7B as possible candidates. We therefore
analyzed the FST profile of an extended genomic region
containing AHI1 and PDE7B. Using HapMap data for
Europeans (CEU) and Yoruba (YRI), we calculated FST
values in 60-SNP sliding windows across a 5-Mb region
centered around the AHI1-MAP7 genomic interval.
SNPs with a MAF  0.05 (averaged over the 2 popula-
tions) were not considered for FST calculation. As
shown in Fig. 5, the region extending from AHI1 to
MAP7 displays relatively high population differentia-
tion; 1 major FST peak corresponds to the terminal
portion of AHI1, while a second extended region with
high population differentiation extends into PDE7B. As
reported above, high FST levels are regarded as an
indication of positive selection (reviewed in ref. 88).
Another expectation under a positive selection regime
is an excess of high-frequency derived alleles. Again,
HapMap data suggested positive selection (Fig. 5).
Resequencing of target regions is considered the most
reliable approach for investigating the evolutionary
history of a genomic region since it allows identification
of all variants in an unbiased way (89).
In a recent study, Yu et al. (51) resequenced 2 regions of
AHI1 covering exons 5–12 and 15–17. By applying a
empirical comparison with random genomic regions, they
indicated that the gene has been subjected to positive
selection. Here we sequenced 11 kb in AHI1 in 40
HapMap subjects (20 CEU and 20 YRI). In particular, we
selected a region covering rs2614276, one of the most
strongly associated SNPs in our sample, and rs17707754,
which is involved in susceptibility to autism (45). This region
is located downstream exon 17 and includes exon 24.
Nucleotide diversity was assessed using 2 indexes: W
(90), an estimate of the expected per site heterozygosity,
and  (80), the average number of pairwise sequence
nucleotide differences. To compare the values obtained
for the AHI1 gene region, we calculated W and  for 238
genes resequenced by the NIEHS program in CEU and YRI;
the percentile rank in the distribution of NIEHS gene
values is reported in Table 5 and indicates that the AHI1
gene region displays low nucleotide diversity in CEU.
Application of commonly used neutrality tests such as
Tajima’s D (DT; ref. 77), Fu and Li’s D* and F* (78), as
well as Fay and Wu’s H (81) did not allow rejection of
the null neutral model for the AHI1 genomic region in
either CEU or YRI (Table 5). Conversely, the Ewens-
Watterson homozygosity test (79) gave a nearly signifi-
cant result (Table 5) in CEU. Under neutral evolution,
the amount of within-species diversity is predicted to
correlate with levels of between-species divergence,
since both depend on the neutral mutation rate. The
Figure 2. Plot of log10 P values for TDT association test across the 9-Mb linkage region to schizophrenia on chromosome
6q23.3 (131.32–140.24 Mb). Reference red lines indicate thresholds for significance (solid line, P10E-5; dashed line,
P10E-3). Arrow indicates best association findings within the AHI1 locus.
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TABLE 3. Single SNP association result for the 500 kb (135.6–136.1 Mb) with the strongest association signal in our scan
SNP Position (bp) Gene HW P Minor allele OTA P q
rs1052502 135648258 AHI1 — T C 3.58E-01 —
rs7766656 135659294 AHI1 — G A 5.07E-01 —
rs2207000 135665526 AHI1 — T C 3.34E-01 —
rs6931735 135666504 AHI1 — G A 3.60E-03 —
rs6912933 135669227 AHI1 — G A 4.16E-04 2.33E-02
rs4896143 135676793 AHI1 — G C 5.47E-03 —
rs6914831 135681337 AHI1 — C T 2.33E-03 —
rs9389286 135682658 AHI1 — G C 6.53E-03 —
rs2064430 135684449 AHI1 — T C 2.31E-03 —
rs9321502 135697945 AHI1 — C A 5.88E-03 —
rs2244745 135704514 AHI1 — T A 1.10E-03 3.93E-02
rs2746430 135714985 AHI1 — A T 3.92E-03 8.20E-02
rs2614276 135723397 AHI1 0.0260 T C 3.96E-04 2.33E-02
rs2246943 135733209 AHI1 — A T 4.95E-03 —
rs2746432 135738290 AHI1 — C T 1.08E-02 —
rs2614264 135752387 AHI1 — G A 2.59E-02 —
rs2614266 135758225 AHI1 — A T 6.36E-03 —
rs2179781 135761193 AHI1 — C A 6.23E-03 —
rs2757649 135768306 AHI1 — C A 9.97E-04 3.76E-02
rs11154801 135781048 AHI1 0.0359 A C 6.23E-06 2.39E-03
rs7759971 135788577 AHI1 T C 1.84E-06 1.58E-03
rs1535435 135798715 AHI1 — A G 9.32E-01 —
rs717120 135806822 AHI1 — C T 4.04E-02 —
rs2614267 135818171 AHI1 — A T 9.96E-04 3.76E-02
rs6908428 135835399 AHI1 — G A 2.93E-04 2.30E-02
rs12206850 135839501 AHI1 0.0317 C T 1.23E-04 2.10E-02
rs4526212 135846324 AHI1 — A C 3.59E-04 2.30E-02
rs9647635 135882749 BC040979 — C A 1.72E-04 2.29E-02
rs9399148 135886052 BC040979 — T A 6.11E-04 2.69E-02
rs9389295 135889916 BC040979 — C T 3.17E-03 —
rs9494266 135893266 BC040979 — A G 5.24E-01 —
rs9402715 135901390 BC040979 — G A 3.17E-03 —
rs9402717 135912471 BC040979 — T C 1.15E-02 —
rs9321508 135919670 BC040979 — A C 1.38E-03 4.20E-02
rs10484771 135939628 BC040979 0.0015 T T 4.09E-01 —
rs2092556 135941037 BC040979 — C C 6.11E-01 —
rs9385729 135962832 BC040979 — G A 5.44E-03 —
rs9321512 135966130 BC040979 — T A 5.44E-03 —
rs4896156 135968556 BC040979 0.0122 G A 5.55E-04 2.50E-02
rs2143681 135974698 BC040979 — A G 8.63E-03 —
rs719885 135981048 BC040979 — G A 2.57E-03 —
rs3734213 135983001 BC040979 0.0087 C T 1.44E-03 4.20E-02
rs7761716 135986074 BC040979 — G A 2.07E-02 —
rs9402729 135993702 BC040979 — A G 4.30E-02 —
rs9494311 136003712 BC040979 — C T 8.16E-02 —
rs9483858 136005501 BC040979 — G A 2.55E-04 2.30E-02
rs10782258 136017953 BC040979 — A T 3.04E-04 2.30E-02
rs6917005 136019673 BC040979 — G A 2.55E-04 2.30E-02
rs9321520 136027787 BC040979 — T C 1.46E-03 4.20E-02
rs9321521 136031343 BC040979 — A G 4.44E-04 2.33E-02
rs10223338 136043720 BC040979 — T C 7.84E-04 3.20E-02
rs9494332 136050301 BC040979 — G A 2.74E-04 2.30E-02
rs9389318 136055227 — C T 1.96E-04 2.29E-02
rs12202212 136060840 — T C 2.63E-04 2.30E-02
rs9321528 136084366 — G C 8.46E-04 3.37E-02
rs2038549 136094641 — A G 9.70E-06 2.77E-03
rs1475069 136097927 — C A 6.97E-06 2.39E-03
rs1033755 136112384 0.0140 A G 1.37E-03 4.20E-02
rs2208574 136117310 0.0021 A G 4.36E-04 2.33E-02
rs9399161 136122157 — G A 1.72E-03 4.76E-02
rs2104132 136126641 — T A 2.23E-03 —
rs9399164 136128239 — T G 9.21E-03 —
rs9402752 136135380 — A T 2.09E-02 —
rs6570039 136138433 — G A 5.79E-03 —
(continued on next page)
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HKA test (91) is commonly used to verify whether this
expectation is verified. Here we applied an MLHKA test
(85) by comparing polymorphisms and divergence
levels at the AHI1 genomic region with 16 NIEHS genes
resequenced in CEU and YRI (see Materials and Meth-
ods). The results are shown in Table 6 and indicate that
a significant reduction in nucleotide diversity vs. diver-
gence is detectable in the CEU sample. These data,
together with the high FST values observed in the region
(ref. 50 and Fig. 5), confirm the previous suggestion
(51) whereby the AHI1 gene region has undergone a
selective sweep in non-African populations. In line with
this view, we noticed that 5 derived alleles have reached
fixation in the CEU sample while remaining polymor-
phic in YRI (Fig. 2); in order to evaluate whether this
feature is unusual for a neutrally evolving region, we
performed 10,000 coalescent simulations by applying a
calibrated population genetics model that incorporates
demographic scenarios (83). The results indicated the
probability of observing 5 fixed derived alleles in CEU
amounts to 0.025, therefore supporting that AHI1 has
been the target of positive selection in this population.
Haplotype analysis
We next analyzed the haplotype genealogy of the AHI1
gene region corresponding to the second haplotype
block along the gene (Fig. 6) by a median-joining
network; this region comprises the 11-kb resequenced
portion, some SNPs strongly associated with schizo-
phrenia in our sample and 6 polymorphic variants
previously shown to define autism-susceptibility haplo-
types (45). To obtain a clear picture of the genealogical
relationship of schizophrenia-predisposing haplotypes
within the network, the 11-kb region was resequenced
in 4 TKT subjects: 3 of them affected with schizophre-
nia and 1 healthy individual. The haplotype data gen-
erated from the resequenced gene region were merged
with HapMap data (for CEU and YRI) and with our
SNP genotyping data for TKT subjects. The resulting
network shows that in the European population, 2
major haplotype clusters exist (clade A and B, Fig. 6),
while African chromosomes are extremely different
from one another and account for 25 different haplo-
types. Interestingly, all TKT chromosomes from af-
fected individuals cluster with clade A, while the 2 chro-
mosomes from the healthy subject are closely related to
clade B. For the autism-susceptibility haplotypes, we found
2 of the 6 markers (rs6570000 and rs6570004) to be
monomorphic in our populations. As a consequence,
only 1 susceptibility haplotype was identified in the pop-
ulation and an extended network analysis (not shown)
indicated that it also clusters with clade A.
DISCUSSION
In previous studies (39–41), we identified by linkage
and association mapping a susceptibility region for
schizophrenia on the long arm of chromosome 6
TABLE 3. (continued)
SNP Position (bp) Gene HW P Minor allele OTA P q
rs9483880 136144305 0.0071 G C 1.03E-02 —
rs981580 136149323 0.0328 G A 1.20E-04 2.10E-02
rs9321532 136153909 0.0071 G A 1.47E-03 4.20E-02
rs9399167 136155509 0.0326 C T 4.21E-03 —
rs6925090 136158170 0.0326 C T 2.28E-03 —
rs1885275 136160513 — A A 8.10E-01 —
rs947583 136175352 — C T 2.87E-05 7.03E-03
rs2009129 136204894 — C T 3.27E-01 —
rs1342236 136206493 — A A 9.45E-01 —
rs6570047 136210916 — C A 8.28E-01 —
Only values of HW P  0.05 and q  0.05 are reported.
TABLE 4. Results from the Mantel-Haenszel joint analysis across TKT and BT samples for the best single marker and haplotype
association results in TKT sample
Marker
Association P
Heterogeneity P Pooled OR and CI95 GeneTKT sample BT sample
Best SNPs
rs7759971-C 1.84E-06 2.20E-01 0.002 1.2 (0.83–1.74) AHI1
rs11154801-C 6.23E-06 2.13E-01 0.002 1.2 (0.83–1.75) AHI1
rs1475069-A 6.97E-06 9.21E-01 0.028 1.88(0.87–1.27) Intergenic
rs2038549-G 9.70E-06 9.21E-01 0.035 1.27(0.87–1.88) Intergenic
Best haplotype windows
rs9389286-rs2064430-rs9321502 3.64E-10 9.34E-01 0.028 1.37(0.92–2.02) AHI1
rs2064430-rs9321502-rs2244745 4.84E-10 9.63E-01 0.028 1.36(0.92–2.02) AHI1
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(6q23.3). This finding was replicated in a recent inde-
pendent Icelandic case control study (42). The peak
region includes the Abelson helper integration site 1
gene AHI1 and a putative gene encoding the human-
specific hypothalamic mRNA BC040979.
Here we have densely mapped the most probable
candidates for schizophrenia by performing a fine
mapping of the originally identified entire linkage
region. With this uniform and denser mapping study
through the entire region, as compared with the can-
didate gene perspective of our previous analyses, we
aimed at obtaining a stronger validation of our find-
ings.
The strongest single SNP and haplotype association,
from rs6931735 and rs2614276, lies within a 500-kb
genomic region (135.6–136.1 Mb) encompassing the
neurodevelopmental AHI1 gene and the BC040979
locus, supporting the role of AHI1 as a susceptibility
Figure 3. Plot of statistical significance (log10 P) values of TDT association test of the SNPs mapping the AHI1 (red), BC040979
(blue), PDE7B (yellow), andMAP7 (green) locus (135.59–137.03 Mb, from rs4895445 to rs3765259). All intergenic SNPs are
black. Reference lines indicate the thresholds for significance (solid line, P10E-5; dashed line, P10E-3).
Figure 4. Sliding-window haplotype analysis. A) Overview of 3-SNP sliding-window haplotype analysis strategy. B) Most significant
haplotype cluster encompassed SNPs from rs6931735 and rs2614276 mapping in AHI1 gene.
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gene for schizophrenia. The known features of AHI1
make it a very attractive candidate gene to schizophre-
nia, even if its biological function has not been yet
completely elucidated.
AHI1 is expressed at high levels in both fetal and
adult brain, in particular in brain areas putatively
involved in schizophrenia (cerebral cortex, hippocam-
pus, and mesolimbic pathway; refs. 92, 93) and seems to
be involved in brain development (43). Mutations in
this gene cause 1 form of Joubert syndrome (JS-OMIM:
Figure 5. Analysis of FST, allele frequency spectra, and LD using HapMap data. Top: Sliding-window analysis of FST between YRI
and CEU in a 5-Mb region centered around the AHI1-MAP7 genomic interval. Windows of 60 SNPs with a step of 20 were used.
Middle: Derived allele frequencies for YRI and CEU; SNPs with AHI1 are shown; each variant position is represented with a
vertical line. Intron-exon structure of the gene is shown beneath. Bottom: linkage disequilibrium blocks in CEU.
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213300; ref. 44), a rare recessive brain disorder charac-
terized by complex congenital brain stem malforma-
tions. The main feature of JS is the lack of corticospinal
tract and superior cerebellar peduncles (94, 95) due to
abnormal axonal guidance or neuronal differentiation
processes. AHI1 has been proposed as a potential
downstream effector of axon guidance pathways. Inter-
estingly, the AHI1 locus appears to be associated to
another neurodevelopmental psychiatric disorder as
autism, even if with different alleles than schizophrenia
(45). Moreover, 25% of JS patients show features of
autistic disorder (46). These convergences on the AHI1
locus suggest that it may have an important role in
human cognition and behavior. Our data support this
hypothesis showing that susceptibility haplotypes for
schizophrenia and autism cluster in the same clade.
A recent molecular finding in mice (96) shows that
AHI1 interacts with Hungtingtin-associated protein 1
(Hap1), which is involved in intracellular trafficking
and TrkB (tyrosine kinase type B) receptor internaliza-
tion. AHI1 and Hap1 form stable protein complex
structures identical to the stigmoid bodies seen in
neurons where AHI1 has a preferential localization,
hippocampus and brainstem (97). Stigmoid bodies
have been suggested to be involved in many processes
(RNA storage center, an inactive microtubule organiz-
ing center, vesicular trafficking, and a direct inhibitor
of mitosis or a marker of postmitotic events; ref. 98).
This scenario fits with the contemporary presence of
domains (SH3, WD40) involved in specific protein-
protein interactions. Moreover, TrkB plays a role in
neuronal differentiation and brain development through
the signaling cascade activated by the brain-derived
neurotrophic factor (BDNF; refs. 99, 100). BDNF is a
potential susceptibility gene for schizophrenia (101,
102) with multiple studies reporting a deficit of BDNF
in the prefrontal cortex of schizophrenic patients (103,
104). These data all together suggest that AHI1 could
play a role in cell signaling and intracellular trafficking
(105).
The association of a crucial gene for neurodevelop-
ment like AHI1 is consistent with the neurodevelop-
mental model of schizophrenia (7, 106), which is the
prevailing disease model to date.
The region where we detected the strongest associa-
tion to schizophrenia also includes BC040979, a gene
with brain expression whose function has not been
already clarified. BC040979 lies in close vicinity to
AHI1, within the same large LD block, and interestingly
they are transcribed in opposite directions with their 5
terms being only 61 bp apart: this raises the possibility
that they are transcribed in a way that is strictly inter-
dependent with the transcription state of the other one.
We also detected a strong association signal with 2
markers, rs2038549 and rs1475069, mapping in the
region between the 3 of BC040979 and the 5 of
PDE7B. These markers do not belong to the LD block
containing PDE7B, but it is possible that transcription
regulatory elements in LD with our markers map in the
region upstream of PDE7B.
We also found 15 SNPs that deviate from HWE in
cases only: we speculate that this finding may further
support association, as already shown by many authors
(61–63).
Interestingly, we had suggestive hits in the region
that includes the PDE7B and MAP7 genes, even if the
mapping SNPs did not survive correction for multiple
testings. Given that they do not lie inside the same LD
block, despite being adjacent, it is possible to exclude
that the association signals detected are merely due to
LD to AHI1. Although to date a direct interaction
among PDE7B, MAP7, and AHI1 has not been reported,
there is evidence of a possible functional interaction. In
fact AHI1 and MAP7 are predicted to be functional
partners of PDE7B, as shown in Fig. 7, with a possible
functional overlap between their pathways.
PDE7B belongs to the large superfamily of phos-
phodiesterases and is involved in the control of cAMP-
mediated neural activity and cAMP metabolism in the
brain (107). PDE7B shows a widespread expression in
human brain in many brain areas with a differential
expression pattern that peaks during the hippocampal
formation and in the cerebellum (108), the main brain
structures affected by schizophrenia and JS, respec-
tively.
MAP7 is mainly expressed in cells of epithelial origins
(109) and brain. Its putative role in schizophrenia is
supported by multiple findings. First, it is involved in
microtubule stabilization, and schizophrenia has been
associated with DISC1, a multifunctional protein acting
TABLE 5. Summary statistics for the evolutionary analysis of the AHI1 gene region
Pop.
W
a a DT
b D*b F*b EWc
Value Rank Value Rank Value Rank Value Rank Value Rank F P
YRI 8.81 0.30 6.68 0.27 0.86 (0.37) 0.26 0.07 (0.21) 0.70 0.30 (0.32) 0.61 0.060 0.17
EU 2.66 0.12 2.82 0.16 0.19 (0.41) 0.60 1.38 (0.13) 0.18 1.02 (0.19) 0.24 0.39 0.056
Pop., population; EW, Ewens-Watterson. a	stimation per site (
104). bP values in parenthesis were obtained by applying a calibrated
population genetics model; rank is by percentile relative to the distribution of 238 NIEHS genes. cEW homozygosity test of neutrality with
Slatkin’s exact P value.
TABLE 6. Summary statistics by population for the evolutionary
analysis of the AHI1 gene region
Fixed substitutions
YRI EU
k P k P
92 1.62 0.78 0.52 0.047
k, selection parameter.
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on microtubules (110). Second, MAP7 acts as a stable
tubule-only polypeptide (STOP; ref. 111) protein, and
STOP suppression in mice was shown to affect both
long- and short-term synaptic plasticity in the hip-
pocampus, to deplete vesicular pools in glutamatergic
nerve terminals and to cause severe behavioral disor-
ders (112). Recently, it has also been reported that
STOP-null mice models for schizophrenia, together
with deficit in both recognition and long-term potenti-
ation, show neuroanatomical deficits that in some way
are reminiscent of those observed among individuals
with schizophrenia (113).
Even if we do not propose a model of interaction
between those genes and known candidate genes for
Figure 6. Genealogy of AHI1 haplotypes recon-
structed through a median-joining network. Re-
gion corresponding to the second LD block was
analyzed, as described in the text. Each node
represents a different haplotype, with the size of
the circle proportional to the haplotype fre-
quency. Colors indicate population: red, YRI;
blue, CEU; gray, affected TKT subjects; green,
healthy TKT subjects. Chimpanzee sequence is
shown as a black circle. Nucleotide differences be-
tween haplotypes are indicated on the branches.
Figure 7. Plots of predicted interaction partnership of the AHI1 and MAP7 genes. Red rectangles indicate the PDE7B gene that
interacts with both AHI1 and MAP7. Although a direct interaction between those genes has not been reported to date, AHI1 and
MAP7 converge on the PDE7B gene in terms of predicted functional interaction.
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schizophrenia, there are multiple links between them
that can be found by simple information retrieving.
Figure 8 shows some of the most interesting interactors
of AHI1, PDE7B, and MAP7, many of which are candi-
date genes to schizophrenia or are involved in other
brain pathways and processes.
The apparent paradox by which schizophrenia-pre-
disposing alleles have been maintained in human pop-
ulations despite the fitness cost and fertility reduction
experienced by the affected subjects has led in recent
years to much scientific debate (114–118). Different
evolutionary “payoffs” for the maintenance of suscepti-
bility alleles have been invoked (117, 118). Conversely,
other authors suggested that an evolutionary model
based on polygenic mutation-selection balance prop-
erly fits the available data on common mental disorders
(116). Yet, evidence in support of either hypothesis has
been lacking. A comprehensive analysis (49) of known
genes involved in schizophrenia indicated that evi-
dence for positive selection can be identified in a
number of cases. Consistently, other researchers (119)
reported that a portion of genes involved in brain
metabolic processes affected in schizophrenia might
have undergone adaptive evolution in humans. The
data we report here support the previous indication
(51) that AHI1 has undergone a selective sweep in
Europeans. Most neutrality tests failed to reject neutral
evolution at AHI1; yet recent works (81, 120, 121)
addressed the power of these commonly used statistics
to reject neutrality and indicated that the strength and
timing of the selective pressure, as well as the allele
frequency of the selected allele and its location relative
to the resequenced region can heavily affect statistical
power. Our data indicate that the 11-kb region we
resequenced displays a significant reduction of poly-
morphisms compared with divergence, as addressed by
the MLHKA test, which is among the most powerful
tests for positive selection (121). Indeed, we also no-
ticed that the number of derived alleles that reached
fixation in Europeans is higher than expected under
neutrality while being polymorphic in Yorubans. These
data therefore fit the hypothesis that genes involved in
schizophrenia are frequent targets of natural selection.
Still, inference about non-neutral evolution alone does
not provide insight into the relationship between
schizophrenia-predisposing alleles and selective pro-
cesses. Specifically, the question whether risk alleles
have been selected for (because they conferred some
advantage in specific circumstances) or against (be-
cause they represented maladaptive variants in relation
to either mental disorders or other traits) remains
open. Alternatively, schizophrenia risk alleles might have
hitchhiked with variants subjected to positive selection
rather than being the selection target themselves. Re-
Figure 8. Plots of one of the hypothetical
networks linking AHI1, PDE7B, and MAP7.
Some of their partners shown have been
previously reported to be involved in
schizophrenia and in other brain pathways
or processes.
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cently, Carrera et al. (122) indicated that the ancestral
susceptibility model might apply to schizophrenia for
variants in MAOB. This same model does not fit AHI1
data, as indicated by our haplotype analysis. Indeed,
schizophrenia susceptibility haplotypes cluster with a ma-
jor haplotype clade, suggesting that they have risen in
frequency possibly through hitchhiking with a linked
selected allele. Similar findings have been reported for
DRD4 (123) for which susceptibility variants for schizo-
phrenia and other behavioral disturbances (e.g., ADHD)
have increased in human populations due to positive
selection and linkage to the 7-repeat allele of a 48 bp
tandem repeat. Similarly, the -2 allele of haptoglobin,
which has also been associated with schizophrenia (10), is
thought to have rapidly spread among humans due to its
conferring stronger immune response (124).
Overall, these data indicate that further studies are re-
quired to address the link between schizophrenia predispo-
sition and selective events, since the underlying evolutionary
model (if any) might be different at distinct loci.
Our data confirm and definitely support the role of
AHI1 as a susceptibility gene for schizophrenia, confirm
its being subjected to positive selection, and even shed
light on new possible candidates like MAP7 and PDE7B
that putatively interact with genes that have been previ-
ously reported to be involved in schizophrenia and in
other brain pathways or processes. Nevertheless, as this
locus is still not mapped with the highest resolution
possible, this assignment has to be considered preliminary
to deep sequencing, which is by now the most advanced
technique to map loci associated with complex diseases.
Sequencing will also allow us to determine the regulatory
elements of this locus, which will help us to understand
how AHI1 expression is regulated.
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